Inquiry Basket
Loading ......
Filter By Product Search for
ABCF2
ABCF2 Full Name
ATP-binding cassette, sub-family F (GCN20), member 2
ABCF2 Introduction
ATP-binding cassette sub-family F member 2 (ABCF2) is a highly unique and evolutionarily conserved member of the expansive ATP-binding cassette (ABC) superfamily. While the vast majority of ABC proteins (such as the ABCA subfamily) operate as integral transmembrane pumps that transport substrates across cellular lipid bilayers, ABCF2 fundamentally deviates from this structural blueprint. It completely lacks the characteristic transmembrane domains (TMDs). Instead, ABCF2 is a soluble, purely intracellular protein consisting entirely of two highly conserved nucleotide-binding domains (NBDs). Due to this structural divergence, ABCF2 does not function as a membrane transporter but rather operates within the cytoplasm as a critical, ATP-dependent regulatory factor.
Figure 1. Structure of an ABC transporter NBD. (Source: Zolnerciks JK, et al. 2011)
Functionally, the precise mechanistic roles of ABCF2 are distinct from traditional lipid or drug efflux pathways. Operating as a soluble ATPase, ABCF2 is heavily implicated in fundamental cellular processes such as protein translation, ribosome dynamics, and cellular stress responses. Like its homologous counterparts in yeast (e.g., GCN20), ABCF2 is believed to physically interact with the ribosome, utilizing the energy derived from ATP hydrolysis to modulate translation elongation or regulate ribosome biogenesis. Furthermore, ABCF2 expression is highly responsive to cellular distress, acting as a crucial survival factor. Under conditions of oxidative stress or exposure to cytotoxic environments, ABCF2 facilitates essential intracellular protein-protein interactions that actively suppress apoptotic signaling cascades and promote cellular viability.
Clinically, the profound anti-apoptotic and pro-survival capabilities of ABCF2 intimately link its dysregulation to severe oncological challenges, most notably multidrug resistance (MDR). ABCF2 is frequently upregulated and significantly overexpressed in various aggressive human malignancies, including clear cell ovarian adenocarcinoma, breast cancer, and hepatocellular carcinoma. In these clinical contexts, elevated ABCF2 levels do not cause drug efflux (since it lacks transport channels) but instead confer robust cellular resistance against standard chemotherapeutic agents, such as cisplatin and paclitaxel, by blocking drug-induced cell death pathways. Consequently, ABCF2 has emerged not only as a valuable prognostic biomarker indicative of poor clinical outcomes but also as a highly compelling molecular target for novel therapeutic strategies aimed at overcoming chemoresistance in refractory tumors.
Alternate Names for ABCF2
ABCF2; ATP-binding cassette, sub-family F (GCN20), member 2; ATP-binding cassette sub-family F member 2; ABC28; EST133090; HUSSY 18; M ABC1; ABC-type transport protein; Iron inhibited ABC transporter 2; iron-inhibited ABC transporter 2; M-ABC1; HUSSY18; HUSSY-18; DKFZp586K1823;
Loading ......
